INTRODUCTION
Asthma affects approximately 8.6% of children in the United States, according to the Centers for Disease Control. During the years [2006] [2007] [2008] [2009] [2010] 38 .4% of children with the disease were poorly controlled; moreover, lack of asthma control has been associated with increased use of the health care system and decreased quality of life. 1, 2 Asthma control is the extent to which the manifestations of the condition are observed or have been improved by treatment. 3 Good control reflects the minimization of the intensity and frequency of symptoms, as well as the overall reduction of functional limitations. 2 Achieving control is a primary goal of asthma care, as it reflects the overall management of underlying airway inflammation, a key driver in the disease process. A principal and critical step in management, therefore, is the assessment of control. 4 As a first step in improving asthma care for our patients, we focused on asthma control by assessing asthma at any visit type. Previously, asthma was not routinely addressed unless it was the reason for the visit or if the patient had acute symptoms such as wheeze or severe cough. There are several tools to evaluate asthma control in the clinical setting. The Asthma Control Test (ACT) and the Childhood Asthma Control Test (C-ACT) are validated tools to identify patients with poorly controlled asthma, and the ACT has been shown to reliably reflect asthma control over time. 5, 6 The ACT is designed for patients 12 years or older, whereas the C-ACT is appropriate for children aged 4-11 years. A score less than 20 on either tool indicates poorly controlled asthma with a sensitivity of 71% and specificity of 71% (ACT) or a sensitivity of 68% and specificity of 74% (C-ACT), as compared with forced expiratory volume in 1 second (FEV1) on spirometry, "the gold standard." 5 These tools were chosen over other asthma screening tools for use in our hospital-wide asthma quality improvement (QI) work because they are reliable, valid, easy to administer, and do not require FEV1 values. 6 Before this project, there was no routine use of standardized and validated tools to assess asthma control With an emphasis on prevention in primary care, the PCN chose to further asthma quality efforts by concentrating on assessment of asthma control. The objective of this QI project was to improve the frequency and consistency of asthma control assessment during patient visits (regardless of visit reason) by increasing completion and documentation of the ACT/C-ACT forms in a large PCN. Specifically, we sought to increase asthma assessment during well child visits, asthma-related visits, sick visits, and follow-up visits for other reasons.
METHODS
This project was exempt by the Institutional Review Board of NCH because it was not deemed human subjects research. We obtained written permission to use the copyrighted instruments from GlaskoSmithKline before incorporating them into our clinical care routine.
The project took place at 11 centers of the NCH PCN from November 2013 to December 2014. There was no baseline data collected before this time period. The PCN has pediatric clinics throughout the greater Columbus, Ohio area, all of which serve a largely urban population, approximately 86% of which are Medicaidinsured. Patients who met the NCH definition of asthma were between the ages of 2-18 years, seen in the PCN within the last 13 months and had an encounter diagnosis of asthma anywhere in the NCH system within the last 24 months. The NCH definition was the same as the PCN network definition. PCN asthma patients are seen both in "regular" clinics and, for those with more challenging disease, in primary care-based asthma specialty sessions. These weekly half-day specialty sessions are run by primary care providers at 9 of our centers and involve extended-length appointments for comprehensive asthma care and education. Both our regular clinic sessions and primary care-based asthma specialty sessions were included and analyzed separately in our ACT/C-ACT intervention. All the PCN providers (90 physicians and 8 nurse practitioners) were involved in this project. The criteria we set for patients who should receive the ACT/C-ACT form were aged 4-18 years and meeting one of the following: a diagnosis of asthma on the electronic medical record (EMR) problem list or a current asthma medication on the patient's record. To assist with identifying which children should have the form completed, an EMR alert was activated at each visit if the patient met the above criteria. We deliberately used a broadened definition of "asthma," distinct from our operational definition described above. This more inclusive patient target (which pulled in children without a formal asthma diagnosis, but who were using albuterol or other asthma medications such as inhaled corticosteroids, long-acting beta agonists, or montelukast) was developed to avoid omitting children who had not been formally diagnosed with asthma, but who needed to have this issue addressed during their clinic visits. Patients less than 4 years were excluded from the alert due to the specified validated age range for the assessment tool. We aimed to assess control at all visit types (well child visits, sick visits for reasons other than asthma, and asthma visits) to maximize our efforts to identify patients with poorly controlled asthma. Ageappropriate ACT/C-ACT paper forms were provided to our patients in English or Spanish by nursing staff (nurses or medical assistants) when rooming the patient. Families speaking other languages completed them with the help of an in-clinic interpreter.
Documentation
Nursing staff were required to document in the EMR one of the following with respect to the ACT/C-ACT: "given," "not given," or "postponed." If "postponed" was chosen, the alert would again activate every time a nursing staff member opened the patient's chart during that visit. Scores were documented in the EMR by the provider either by (1) using a standardized asthma note that included a smartphrase in which the ACT/C-ACT score was entered or (2) by an EMR smartphrase for just the ACT/C-ACT score alone without further documentation of asthma status of the patient. The EMR used at our institution is Epic, which allowed us to query charts for the presence of ACT/C-ACT documentation and scores, based on the use of a smartphrase.
QI Processes
A goal was set for a 70% provider documentation rate of the ACT/C-ACT at any visit type for patients 4 years of age or older meeting criteria for the nursing staff alert by December 2014. The goal of the ACT/C-ACT documentation was set at 70%, rather than a higher percentage, to acknowledge that other pressing issues may take precedence during a clinic visit, or families may experience form fatigue from other forms or multiple asthma visits leading to an inability to complete the survey. Also, the patients targeted by our alert system did not all have a diagnosis of asthma (e.g., a patient with albuterol in their medication list may have used it for a single episode of bronchiolitis). We encouraged providers to update these charts (for this example, discontinue albuterol) as part of the visit and then these charts were no longer counted in our denominator.
Our clinic processes were revised using a series of QI Plan-Do-Study-Act interventions using the Institute for Healthcare Improvement Model for Improvement. 7 Multiple steps were taken to improve clinic compliance with ACT/C-ACT documentation. Because multiple centers conducted these interventions at various times during the project, they cannot be evaluated separately during a specific time frame. The interventions included:
Communication
• A network-wide kick off meeting for all staff occurred at the beginning of the project to emphasize the importance of asthma care.
• Review of hospital-wide and department-specific asthma initiatives, including the ACT/C-ACT, were formally presented to physicians at 3 ambulatory department meetings in 2014.
• Small group interactive meetings, led by the asthma champions, included providers and nursing and registration staff and occurred quarterly at each primary care center.
• Specific ACT/C-ACT information reviewed included the following:
▪ Identifying patients and families who should be given the forms ▪ Responding to alerts in the EMR ▪ Incorporating administration of the ACT/C-ACT into the clinic workflow ▪ Standardized documentation of the ACT/C-ACT in the EMR.
• Issues and barriers to asthma care and our processes were reviewed and potential solutions were discussed by each team.
• Physician and nursing staff education and clinicspecific updates were given at these meetings.
Leadership Development in the PCN
• Three asthma champions were designated and provided full-time equivalent (FTE) support (S.H., J.G., D.S. with a total 0.6 FTE).
• The asthma champions met weekly to review data.
Feedback to Clinics and Providers
• Performance data were given to individual providers.
• Feedback on clinic performance was given quarterly to team members during meetings and via e-mail.
EMR Support
• EMR alerts were developed to aid in reminding nursing staff to distribute ACT/C-ACT forms.
• Alert 1: For eligible patients, reminded staff to give them an ACT/C-ACT form when initially reviewing the chart.
• Alert 2: Allowed staff to defer the first alert so it may later alert them again when they are with the patient.
Incentives
• Quarterly performance monetary incentives ($50) were given to the nonphysician staff if their clinic reached project goals. 
QI Data Methodology
Statistical process control methodologies were used to analyze the collected data. For this analysis, p-charts, which assume binomial data distribution, were developed to track the documentation of ACT/C-ACT at Asthma Specialty Visits, Well Child Visits, and PCN visits overall. A shift was defined as 6 consecutive data points above or below the baseline while a trend was defined as 6 consecutive points in a row, all increasing or all decreasing without a change in direction.
RESULTS
The PCN managed 74,224 unique patients in 2014 with 172,457 total visits. Of those, 8,533 patients met our network's operational definition of a current asthma patient in 2014. Data collection on completion of the ACT/C-ACT began in November 2013. Six months after introduction of the aim and subsequent interventions, our goal of 70% ACT/C-ACT documentation rate was reached for all visit types. This rate has consistently exceeded 70% through 2016 (Fig. 1 ). This is also the case for ACT/C-ACTs documented at asthma specialty visits ( Fig. 2 ) and well child visits (Fig. 3) . Key interventions that occurred during this time period are delineated on the chart and include establishment of 3 PCN asthma champions, incorporation of the ACT/C-ACT into the asthma note, completion of initial staff and physician education, and alerts in the EMR. There were improvements in ACT/C-ACT documentation rates with each major intervention. During the project time period, there were 15,519 ACT/C-ACT scores documented with a mean score of 20 and a median score of 21. All interventions were sustained through 2016.
DISCUSSION
We were able to successfully integrate administration and results documentation of the ACT and C-ACT in a large PCN. We demonstrated that assessment of asthma control can be a regular process in a busy practice with multiple practitioners, even when asthma may not be the primary reason for the visit. It is important to note that this practice change was implemented by over 90 providers and sustained for 2 years after project completion. Our major barrier was the large size of our network and disseminating information to all physicians and staff, as well as staff turnover at the various primary care centers. Other challenges included the integration of a paper screening tool into the flow of an EMR clinic. We overcame these barriers with several interventions and cooperation across disciplines, including utilization of EMR alerts, standardized documentation of an asthma-related encounter, physician and staff education, regular clinical team meetings to review processes, and staff incentives. Future plans to sustain current interventions will include all the processes described here, except the clinic staff incentive. Next steps include tracking the management of those patients found poorly controlled and more specifically, monitoring the step up in medical therapy for these patients.
LIMITATIONS
A limitation of our work is that it had multiple overlapping interventions at a given point in time across the network and was not designed to look at the impact of an individual intervention. Our institutional support (FTE for asthma champions and incentives) and EMR capabilities (ability to use alerts and smartphrases) may not be applicable to other practices. This project did not include balancing measures. This work focused on a process measure, but did not measure outcomes.
